OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. We are developing molecular information products and services for global healthcare settings, helping to guide clinicians with more rapid and actionable information about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms, or MDROs.

Shareholder Tools

Latest News
OpGen Reports First Quarter 2022 Financial Results and Provides Business Update
OpGen to Provide Business Update and Financial Results for the First Quarter 2022 on May 12th at 4:30 p.m. Eastern Time
OpGen’s Subsidiary Curetis and European Investment Bank Plan to Restructure Debt Repayment

btn News

See All News

Upcoming Events
More events are coming soon.

btn Events

See all events